SCHEDULE: Bank of America Discloses 0.0% Stake in ENvue Medical

Bank of America Corporation filed an amended Schedule 13G, disclosing a passive beneficial ownership of 14 common shares, representing 0.0% of ENvue Medical, Inc.

Summary

• Bank of America Corporation filed an Amendment No. 1 to Schedule 13G regarding its beneficial ownership in ENvue Medical, Inc.
• The filing indicates Bank of America beneficially owns 14 shares of ENvue Medical's Common Stock.
• This ownership represents 0.0% of the class of securities, based on 1,088,192 outstanding shares as of December 5, 2025.
• The shares are held with shared voting power and shared dispositive power.
• Bank of America is filing as a parent holding company on behalf of its subsidiaries, BofA Securities, Inc. (a broker-dealer) and Bank of America N.A. (a bank).
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of a very small, passive ownership stake by a large financial institution, with no material implications for ENvue Medical's operations or strategic direction.

Positives

• NA

Negatives

• NA

Risks

• NA

Future Outlook

NA

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures by institutional investors holding less than 20% of a company's stock with a passive investment intent. Bank of America's filing indicates a minimal, non-strategic holding, likely for custodial or brokerage purposes rather than an active investment position in ENvue Medical, Inc. This type of filing is common for large financial institutions that hold shares on behalf of clients or through various operational segments.

Stakeholder Impact

• Minimal impact on shareholders of ENvue Medical, Inc. due to the extremely small, passive nature of the disclosed stake.
• No direct impact on employees, customers, suppliers, or creditors of ENvue Medical, Inc. is indicated by this filing.

Key Dates

Keywords

ENvue Medical, Inc., Bank of America, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Ownership, Passive Investment